Medical Case Details:
A 38-year-old male was found wandering outside his apartment building at night wearing only his under garments was brought to the hospital by ambulance and appeared confused. The patient's family later confirmed that for one week prior, he had severe headaches, nausea and vomiting, slurred speech, and confusion. About few months previously, he had presented to another hospital with new onset seizures, was encephalopathic and was found to be hypothyroid. Extensive work-up had ruled out infectious, toxic, metabolic, malignant and paraneoplastic etiologies and Creutzfeldt–Jakob disease. His TSH levels were 8.08 IU/ml. TPOAb and TgAb were markedly elevated TPOAb >900IU/ml with TgAb >3000 IU/ml.
Initial treatment at the outside hospital with a combination of two anticonvulsants was ineffective. However, after 3 days of prednisone (60 mg/d) his seizures resolved.
At our hospital, he is started on broad-spectrum antibiotics for possible infectious meningitis or encephalitis. Lumbar puncture revealed elevated CSF protein levels 221 mg/dl without pleocytosis.
CSF cultures are negative for common bacteria, acid-fast bacilli, fungi, cryptococcus antigen, herpes DNA PCR. Blood and urine cultures are negative and toxicology screening is negative
How to go forward.
Thanks
Dr. Thakre Mahendra Shivram
General Medicine Physician
Hi,
Looks like you are dealing with a condition called Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT). It is characterized by a combination of elevated thyroid antibodies and altered cognition that cannot be attributed to hypothyroidism or thyrotoxicosis.
It is one of several subcategories of autoimmune encephalopathy, which include HE, paraneoplastic encephalopathy, autoimmune encephalitis with and without known antibodies, primary central nervous system vasculitis, and systemic autoimmune diseases with CNS involvement.
A commonly used empiric course for HE is intravenous methylprednisolone (IVMP) 1000 mg daily for 5 days. Following this course, patients often require a period of maintenance steroid treatment and a slow steroid taper. the the initial dose of 1–2 mg/kg/day, followed by a slow taper over 6–12 weeks.
Patients should be monitored for side effects including hyperglycemia, hypertension, osteoporosis.
While some patients may recover after one clinical episode of HE, relapse of symptoms is common and patients often require steroid-sparing maintenance immunomodulatory therapy.
Regards.
20.Apr, 10:35am